Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.11
(0.0%)
CNY 7.11
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 240.72 Million CNY | -19.76% |
| 2022 | 299.99 Million CNY | -13.62% |
| 2021 | 347.28 Million CNY | 34.02% |
| 2020 | 259.12 Million CNY | -6.79% |
| 2019 | 277.99 Million CNY | 9.2% |
| 2018 | 254.56 Million CNY | -16.16% |
| 2017 | 303.65 Million CNY | -11.56% |
| 2016 | 343.33 Million CNY | 8.45% |
| 2015 | 316.57 Million CNY | 10.97% |
| 2014 | 285.27 Million CNY | -10.51% |
| 2013 | 318.79 Million CNY | 2.56% |
| 2012 | 310.84 Million CNY | 19.5% |
| 2011 | 260.12 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 70.3 Million CNY | 52.44% |
| 2024 Q3 | 66 Million CNY | 79.2% |
| 2024 Q2 | 37.29 Million CNY | -46.95% |
| 2023 Q1 | 71.23 Million CNY | 158.17% |
| 2023 FY | 240.72 Million CNY | -19.76% |
| 2023 Q2 | 56.65 Million CNY | -20.46% |
| 2023 Q4 | 46.11 Million CNY | -39.08% |
| 2023 Q3 | 75.71 Million CNY | 33.63% |
| 2022 Q3 | 101.39 Million CNY | 18.02% |
| 2022 FY | 299.99 Million CNY | -13.62% |
| 2022 Q4 | 27.59 Million CNY | -72.79% |
| 2022 Q1 | 85.08 Million CNY | 6.4% |
| 2022 Q2 | 85.92 Million CNY | 0.99% |
| 2021 FY | 347.28 Million CNY | 34.02% |
| 2021 Q1 | 101.07 Million CNY | 58.56% |
| 2021 Q2 | 67.06 Million CNY | -33.65% |
| 2021 Q3 | 99.18 Million CNY | 47.9% |
| 2021 Q4 | 79.96 Million CNY | -19.38% |
| 2020 Q4 | 63.74 Million CNY | -16.95% |
| 2020 Q1 | 56.67 Million CNY | -7.87% |
| 2020 Q3 | 76.75 Million CNY | 23.88% |
| 2020 Q2 | 61.95 Million CNY | 9.31% |
| 2020 FY | 259.12 Million CNY | -6.79% |
| 2019 Q1 | 80.95 Million CNY | 37.66% |
| 2019 FY | 277.99 Million CNY | 9.2% |
| 2019 Q2 | 57.83 Million CNY | -28.56% |
| 2019 Q4 | 61.51 Million CNY | -20.8% |
| 2019 Q3 | 77.68 Million CNY | 34.31% |
| 2018 Q1 | 61.78 Million CNY | -5.15% |
| 2018 FY | 254.56 Million CNY | -16.16% |
| 2018 Q4 | 58.8 Million CNY | -33.01% |
| 2018 Q3 | 87.78 Million CNY | 90.05% |
| 2018 Q2 | 46.19 Million CNY | -25.23% |
| 2017 Q1 | 73.12 Million CNY | -21.51% |
| 2017 FY | 303.65 Million CNY | -11.56% |
| 2017 Q4 | 65.13 Million CNY | -29.02% |
| 2017 Q3 | 91.77 Million CNY | 24.66% |
| 2017 Q2 | 73.61 Million CNY | 0.66% |
| 2016 Q2 | 79.83 Million CNY | 4.25% |
| 2016 FY | 343.33 Million CNY | 8.45% |
| 2016 Q3 | 93.74 Million CNY | 17.42% |
| 2016 Q1 | 76.58 Million CNY | -4.42% |
| 2016 Q4 | 93.16 Million CNY | -0.62% |
| 2015 Q1 | 71.23 Million CNY | 31.19% |
| 2015 FY | 316.57 Million CNY | 10.97% |
| 2015 Q4 | 80.12 Million CNY | -6.59% |
| 2015 Q3 | 85.77 Million CNY | 7.97% |
| 2015 Q2 | 79.44 Million CNY | 11.53% |
| 2014 FY | 285.27 Million CNY | -10.51% |
| 2014 Q3 | 73.27 Million CNY | -7.65% |
| 2014 Q1 | 78.35 Million CNY | 0.0% |
| 2014 Q2 | 79.34 Million CNY | 1.27% |
| 2014 Q4 | 54.29 Million CNY | -25.9% |
| 2013 FY | 318.79 Million CNY | 2.56% |
| 2012 FY | 310.84 Million CNY | 19.5% |
| 2011 FY | 260.12 Million CNY | 0.0% |